X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (869) 869
Publication (137) 137
Book / eBook (26) 26
Book Chapter (11) 11
Patent (8) 8
Newsletter (4) 4
Web Resource (4) 4
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (356) 356
index medicus (264) 264
female (260) 260
male (242) 242
middle aged (234) 234
aged (222) 222
adult (205) 205
oncology (146) 146
hematology (140) 140
aged, 80 and over (134) 134
prognosis (90) 90
cancer (88) 88
article (85) 85
rituximab (72) 72
lymphomas (69) 69
risk factors (65) 65
treatment outcome (65) 65
young adult (62) 62
adolescent (58) 58
lymphoma (56) 56
disease-free survival (55) 55
chemotherapy (54) 54
research (54) 54
analysis (52) 52
antineoplastic combined chemotherapy protocols - therapeutic use (52) 52
non-hodgkins-lymphoma (51) 51
survival (46) 46
animals (45) 45
care and treatment (43) 43
neoplasm staging (43) 43
survival analysis (42) 42
expression (40) 40
lymphoma, large b-cell, diffuse - drug therapy (40) 40
retrospective studies (38) 38
surgery (38) 38
survival rate (38) 38
b-cell lymphoma (36) 36
hemic and lymphatic diseases (36) 36
abridged index medicus (35) 35
therapy (35) 35
antineoplastic agents - therapeutic use (33) 33
cell biology (33) 33
disease (33) 33
risk (33) 33
follow-up studies (31) 31
prospective studies (31) 31
cohort studies (30) 30
biochemistry & molecular biology (29) 29
genetic aspects (29) 29
non-hodgkin lymphoma (29) 29
case-control studies (26) 26
elderly-patients (26) 26
follicular lymphoma (26) 26
health aspects (26) 26
lymphoma, large b-cell, diffuse - mortality (26) 26
diagnosis (24) 24
medicine & public health (24) 24
medicine, general & internal (24) 24
time factors (24) 24
kaplan-meier estimate (23) 23
medical research (23) 23
multivariate analysis (23) 23
age factors (22) 22
cyclophosphamide - administration & dosage (22) 22
gene expression (22) 22
genetics & heredity (22) 22
lymphoma, large b-cell, diffuse - pathology (22) 22
patients (22) 22
united states (22) 22
antibodies, monoclonal - therapeutic use (21) 21
antibodies, monoclonal, murine-derived (21) 21
lymphoma, non-hodgkin - pathology (21) 21
mortality (21) 21
non-hodgkin-lymphoma (21) 21
recurrence (21) 21
antineoplastic combined chemotherapy protocols - administration & dosage (20) 20
doxorubicin - administration & dosage (20) 20
epidemiology (20) 20
genes (20) 20
non-hodgkin's lymphomas (20) 20
proteins (20) 20
vincristine - administration & dosage (20) 20
genomes (19) 19
genomics (19) 19
immune system diseases (19) 19
immunohistochemistry (19) 19
medicine, experimental (19) 19
association (18) 18
leukemia (18) 18
proportional hazards models (18) 18
tumors (18) 18
life sciences (17) 17
pathology (17) 17
polymorphism, single nucleotide (17) 17
prednisone - administration & dosage (17) 17
aneuploidy (16) 16
chemotherapy plus rituximab (16) 16
child (16) 16
chop (16) 16
cyclophosphamide (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (4) 4
Robarts - Stacks (4) 4
Architecture Landscape (Shore + Moffat) - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Engineering & Comp. Sci. - Missing (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Robarts - Not Returned (1) 1
St. Michael's Hospital - Stacks (1) 1
Victoria University CRRS - Library use only (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2006, 7th ed., ISBN 9780849390593, xci, 1035
Book
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2811 - 2811
Background: FDG PET/CT and bone marrow biopsy (BMB) are considered standard procedures for the staging of patients with new, untreated FL. A key issue in FL is... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5352 - 5352
Background Burkitt NHL (BL) is a rare hematologic malignancy that occurs in younger adults and is highly curable with aggressive chemoimmunotherapy induction... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4129 - 4129
Background: Neurolymphomatosis (NL) is a highly rare disorder defined as infiltration of peripheral nervous system by a lymphoproliferative neoplasm, both... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5401 - 5401
Abstract Introduction Primary testicular lymphoma (PTL) and testicular involvement of systemic lymphoma (secondary testicular lymphoma, STL) are uncommon. Most... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4208 - 4208
Abstract Background: The majority of subjects with a diagnosis of primary central nervous system lymphoma (PCSNL) have diffuse large B-cell lymphoma (DLBCL) as... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1717 - 1717
Abstract Introduction: Clinical tumor lysis syndrome (TLS), which manifests most often as acute kidney injury (AKI) is a common and devastating complication of... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1628 - 1628
Acute kidney injury (AKI) is common in those with newly diagnosed hematologic malignancies. Precipitants of AKI in this population may include tumor lysis... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 5215 - 5215
Purpose The development of cardiovascular disease (CVD) is a relatively rare but a clinically important adverse event in the treatment of lymphoma,... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 454 - 454
Abstract Introduction: The addition of Rituximab to chemotherapy has significantly improved the outcome of patients with newly diagnosed diffuse large B-cell... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 4139 - 4139
Abstract Introduction. The peripheral blood absolute lymphocyte (ALC)/monocyte (AMC) ratio (ALC/AMC), as a surrogate of host immunity (i.e. ALC) and tumor... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4010 - 4010
INTRODUCTION: EMZL is a heterogeneous disease with variable risk for relapse and progression. Based on age ≥70 years, stage III-IV and elevated LDH,... 
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 03/2019, Volume 60, Issue 4, pp. 920 - 926
Journal Article
Leukemia & lymphoma, ISSN 1042-8194, 09/2019, pp. 1 - 11
One-in-five Hodgkin Lymphoma (HL) patients treated with bleomycin develop bleomycin pulmonary toxicity (BPT). Given bleomycin-omission data with negative... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 1693 - 1693
Abstract MYC amplification (amp) is a marker of poor prognosis in many non-hematologic malignancies. While MYC translocations in B cell lymphoma (BCL) have... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 1750 - 1750
Abstract Introduction: "High grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements" (HG DH/THL) is a new diagnosis per the revised 2016 WHO... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2018, Volume 378, Issue 6, pp. 549 - 562
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3885 - 3885
Abstract The lymphocyte-to-monocyte ratio at diagnosis (LMR-D) has been reported to be a prognostic factor for clinical outcomes in both T-cell and B-cell... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.